logo
Sign in

GSAC Stock Price, Chart, Stats & News

GelStat Corporation
Save

GelStat Corporation (GSAC) does not currently pay a dividend.

185,394
Market cap
Current P/E
Forward P/E

GSAC chart

1M
3M
1Y
5Y
Loading chart...

About

Health care
Sector
Medical - Pharmaceuticals
Industry

GelStat Corporation operates as a consumer healthcare enterprise, specializing in the innovation, formulation, and commercialization of over-the-counter (OTC) and other non-prescription health solutions. Its diverse product portfolio addresses various common health concerns, featuring: GelStat Migraine, a patented remedy targeting migraine headache pain; Chews 2 Lose, an appetite-controlling gum designed to assist with weight management; All Natural Speed, formulated as an energy booster; and GelStat Sleep, intended to alleviate sleep disturbances and their related symptoms. GelStat distributes its solutions through a comprehensive network, reaching retailers, wholesalers, specialized distributors, and catalog merchandisers.

Similar securities

Based on sector and market capitalization

Report issue